Hedong Han

1.2k total citations
54 papers, 824 citations indexed

About

Hedong Han is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hedong Han has authored 54 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Cardiology and Cardiovascular Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hedong Han's work include Heart Failure Treatment and Management (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (6 papers). Hedong Han is often cited by papers focused on Heart Failure Treatment and Management (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (6 papers). Hedong Han collaborates with scholars based in China, Sweden and United States. Hedong Han's co-authors include Jia He, Yang Cao, Xin Fang, Jan Aaseth, Wei Guo, Yamei Yu, Yunshuo Zhang, Wentao Shi, Xiaofei Ye and Zhongjie Fan and has published in prestigious journals such as Scientific Reports, Spine and CHEST Journal.

In The Last Decade

Hedong Han

51 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hedong Han China 14 208 183 138 133 109 54 824
Chor‐Wing Sing Hong Kong 19 122 0.6× 114 0.6× 156 1.1× 95 0.7× 77 0.7× 41 1.0k
Rob J. Kraaijenhagen Netherlands 25 261 1.3× 93 0.5× 101 0.7× 87 0.7× 126 1.2× 46 1.6k
Paulette D. Chandler United States 16 275 1.3× 154 0.8× 81 0.6× 250 1.9× 237 2.2× 37 1.2k
Nahid Karamzad Iran 17 206 1.0× 54 0.3× 160 1.2× 181 1.4× 183 1.7× 41 1.2k
Verena Katzke Germany 19 80 0.4× 215 1.2× 63 0.5× 175 1.3× 185 1.7× 49 1.0k
Eduard Sidelnikov Switzerland 13 145 0.7× 108 0.6× 69 0.5× 79 0.6× 87 0.8× 40 787
Yongjian Zhu China 17 101 0.5× 74 0.4× 132 1.0× 104 0.8× 134 1.2× 55 932
Michele F. Eisenga Netherlands 21 216 1.0× 95 0.5× 134 1.0× 79 0.6× 198 1.8× 89 1.5k
Yap‐Hang Chan Hong Kong 23 234 1.1× 164 0.9× 532 3.9× 108 0.8× 111 1.0× 77 1.5k

Countries citing papers authored by Hedong Han

Since Specialization
Citations

This map shows the geographic impact of Hedong Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hedong Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hedong Han more than expected).

Fields of papers citing papers by Hedong Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hedong Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hedong Han. The network helps show where Hedong Han may publish in the future.

Co-authorship network of co-authors of Hedong Han

This figure shows the co-authorship network connecting the top 25 collaborators of Hedong Han. A scholar is included among the top collaborators of Hedong Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hedong Han. Hedong Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Yanjun, et al.. (2025). Antibody-drug conjugates outperform chemotherapy in EGFR-TKI-resistant NSCLC: a Bayesian network meta-analysis. Therapeutic Advances in Medical Oncology. 17. 22849780–22849780.
2.
3.
Kang, Wenwen, Jing Cheng, Lanlan Pan, et al.. (2024). Heterogeneity between subgroups of first-line chemoimmunotherapy for extensive-stage small cell lung cancer patients: a meta-analysis and systematic review. Frontiers in Oncology. 14. 1334957–1334957. 1 indexed citations
4.
Han, Hedong, et al.. (2024). Comparison of antifungal drugs in the treatment of invasive pulmonary aspergillosis: a systematic review and network meta-analysis. Frontiers in Microbiology. 15. 1504826–1504826. 2 indexed citations
5.
Chen, Yueying, Hedong Han, Jing Cheng, et al.. (2024). Efficacy and safety of anti-PD-1/PD-L1-based dual immunotherapies versus PD-1/PD-L1 inhibitor alone in patients with advanced solid tumor: a systematic review and meta-analysis. Cancer Immunology Immunotherapy. 73(8). 155–155. 11 indexed citations
6.
7.
Jin, Jiewen, Xian-Ying Zhu, Zhantao Deng, et al.. (2023). Protein-energy malnutrition and worse outcomes after major cancer surgery: A nationwide analysis. Frontiers in Oncology. 13. 970187–970187. 6 indexed citations
8.
9.
Wang, Yimin, Hedong Han, Fang Zhang, et al.. (2022). Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis. British Journal of Cancer. 127(5). 948–956. 22 indexed citations
10.
Han, Hedong, Cheng Wu, Xin Wei, et al.. (2021). Discharge Against Medical Advice in Acute Ischemic Stroke: the Risk of 30-Day Unplanned Readmission. Journal of General Internal Medicine. 36(5). 1206–1213. 8 indexed citations
11.
Han, Hedong, Wei Guo, Xin Wei, et al.. (2021). Atrial fibrillation in critically ill patients who received prolonged mechanical ventilation: a nationwide inpatient report. The Korean Journal of Internal Medicine. 36(6). 1389–1401. 1 indexed citations
12.
Zhou, Li, Yanling Lv, Zimu Wang, et al.. (2021). Association of MUC19 Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung Cancer. Frontiers in Oncology. 11. 596542–596542. 8 indexed citations
13.
Wang, Yang, Yu Zhang, Yicun Wang, et al.. (2021). Chronic Thrombocytopenia and In-Hospital Outcomes After Primary Total Hip and Knee Arthroplasty. The Journal of Arthroplasty. 37(1). 19–25.e4. 3 indexed citations
14.
Han, Hedong, Li Zhou, Xi Chen, et al.. (2021). Evaluation of the Lung Immune Prognostic Index in Non-Small Cell Lung Cancer Patients Treated With Systemic Therapy: A Retrospective Study and Meta-Analysis. Frontiers in Oncology. 11. 670230–670230. 11 indexed citations
15.
Jin, Jiewen, Zhantao Deng, Lijuan Xu, et al.. (2020). Prior bariatric surgery and perioperative cardiovascular outcomes following noncardiac surgery in patients with type 2 diabetes mellitus: hint from National Inpatient Sample Database. Cardiovascular Diabetology. 19(1). 103–103. 2 indexed citations
16.
Han, Lin, Hedong Han, Liang Wang, et al.. (2020). Prior bariatric surgery is associated with lower complications, in-hospital mortality, and healthcare utilization after elective spine fusion surgery. Surgery for Obesity and Related Diseases. 16(6). 760–767. 5 indexed citations
17.
Han, Hedong, Lihong Chen, Meng Wang, et al.. (2019). Benefits of bariatric surgery in patients with acute ischemic stroke—a national population-based study. Surgery for Obesity and Related Diseases. 15(11). 1934–1942. 5 indexed citations
18.
Han, Hedong, et al.. (2019). Impact of prior bariatric surgery on outcomes of hospitalized patients with heart failure: a population-based study. Surgery for Obesity and Related Diseases. 15(3). 469–477. 19 indexed citations
19.
Fang, Xin, Mei Li, Hedong Han, et al.. (2018). Does dietary intake of selenium protect against cancer? A systematic review and meta-analysis of population-based prospective studies. Critical Reviews in Food Science and Nutrition. 60(4). 684–694. 61 indexed citations
20.
Han, Hedong, Wei Guo, Wentao Shi, et al.. (2017). Hypertension and breast cancer risk: a systematic review and meta-analysis. Scientific Reports. 7(1). 44877–44877. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chor‐Wing Sing Breakdown of academic impact, for papers by Rob J. Kraaijenhagen Breakdown of academic impact, for papers by Paulette D. Chandler Breakdown of academic impact, for papers by Nahid Karamzad Breakdown of academic impact, for papers by Verena Katzke Breakdown of academic impact, for papers by Eduard Sidelnikov Breakdown of academic impact, for papers by Yongjian Zhu Breakdown of academic impact, for papers by Michele F. Eisenga Breakdown of academic impact, for papers by Yap‐Hang Chan
Rankless by CCL
2026